Search All News
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
A new study in women found that shortening sleep by just 90 minutes for a few weeks increased insulin resistance, a risk factor for type 2 diabetes.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
- November 21, 2017
2017 Naomi Berrie Award winner Bradford B. Lowell, MD, PhD, is an innovator in creating cutting-edge genetic engineering and neuroscience techniques to study energy balance and obesity.
- October 24, 2017
Researchers may have found a way to treat insulin resistance, a precursor to type 2 diabetes, while avoiding side effects such as weight gain.
- July 12, 2017
Michael Rosenbaum, MD, director of the new FIT clinic at Columbia for treatment of pediatric obesity, explains his research on weight loss and metabolism.
- June 28, 2017
Two 20-somethings, Berrie Center patient Emily Goldman and her "diabestie" Christie Leist, share their trials and tribulations of living with T1D.
- June 27, 2017
A communitywide intervention for families who receive WIC benefits reduced obesity risk factors in preschoolers.
- April 5, 2017
The Naomi Berrie Diabetes Center has launched an initiative to study the relationship between the brain and metabolic disorders such as obesity and diabetes.
- December 12, 2016
Columbia University researchers have discovered an enzyme deficiency in the brain that is linked to Prader-Willi, a rare obesity syndrome.